Journal of Bone and Mineral Metabolism

, Volume 26, Issue 4, pp 328–334 | Cite as

Sodium fluoride modulates caprine osteoblast proliferation and differentiation

  • Wei-Jie Qu
  • Dai-Bin Zhong
  • Pei-Fu Wu
  • Jian-Fang Wang
  • Bo HanEmail author
Original Article


The cellular and molecular pathways of fluoride toxicity in osteoblasts are not very well understood. Therefore, the objective of the present study was to evaluate the effects of sodium fluoride (NaF) on caprine osteoblasts cultured in vitro. Caprine osteoblasts at 2.0 × 10−4 cells/ml were incubated in vitro with NaF at 0, 10−8, 10−7, 10−6, 10−5, 10−4, 5.0 × 10−4, and 10−3 M, and then proliferation, differentiation, apoptosis, calcification, and alkaline phosphatase activity were examined. Also, the effect of NaF on osteoblastic cell viability and the molecular events leading to apoptosis were determined. Electron microscopy revealed cytoplasmic and nuclear alterations in the ultrastructure of osteoblasts exposed to various NaF concentrations. A cell-based quantitative evaluation of the MTT assay showed that NaF at concentrations of 10−8 to 10−5 M promoted cell proliferation, whereas at 10−4 to 10−3 M it suppressed cell proliferation and induced apoptosis. Alkaline phosphatase (ALP) activity and mineralization ability increased in cells treated at 10−8 to 10−5 M with sodium versus the controls, but decreased at 5.0 × 10−4 to 10−3 M dosage. The highest incidence of early apoptotic cells and late apoptotic cells was reached (3.33% and 2.92%, respectively) under NaF concentration of 10−4 M. In conclusion, results of this study indicated that NaF modulates osteoblast proliferation and differentiation in a dose-dependent manner and modified osteoblast metabolism bidirectionally, suggesting NaF may play a significant role in osteoblast physiology.

Key words

sodium fluoride osteoblast proliferation differentiation apoptosis 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Gabuda SP, Gaidash AA, Kozlova SG, Allan NL (2006) Structural forms of fluorides in bone tissue of animals under chronic fluoride intoxication. J Struct Chem (Engl Transl) 47:258–266Google Scholar
  2. 2.
    Mackie EJ (2003) Osteoblasts: novel roles in orchestration of skeletal architecture. Int J Biochem Cell Biol 35:1301–1305PubMedCrossRefGoogle Scholar
  3. 3.
    Khandare AL, Suresh P, Kumar PU, Lakshmaiah N, Manjula N, Rao GS (2005) Beneficial effect of copper supplementation on deposition of fluoride in bone in fluoride-and molybdenum-fed rabbits. Calcif Tissue Int 77:233–238PubMedCrossRefGoogle Scholar
  4. 4.
    Mathias RS, Amin U, Mathews CHE, Denbesten P (2000) Increased fluoride content in the femur growth plate and cortical bone of uremic rats. Pediatr Nephrol 4:935–939CrossRefGoogle Scholar
  5. 5.
    Choubisa SL (1999) Some observations on endemic fluorosis in domestic animals in southern Rajasthan (India). Vet Res Commun 23:457–465PubMedCrossRefGoogle Scholar
  6. 6.
    Goltzman D (2002) Discoveries, drugs and skeletal disorders. Nature (Lond) 1:784–796CrossRefGoogle Scholar
  7. 7.
    Tasat DR, Orona NS, Mandalunis PM, Cabrini RL, Ubios AM (2006) Ultrastructural and metabolic changes in osteoblasts exposed to uranyl nitrate. Arch Toxicol 81:319–326PubMedCrossRefGoogle Scholar
  8. 8.
    Tanaka-Kamioka K, Kamioka H, Ris H, Lim SS (1998) Osteocyte shape is dependent on actin filaments and osteocyte processes are unique actin-rich projections. J Bone Miner Res 13:1555–1568PubMedCrossRefGoogle Scholar
  9. 9.
    Yuan LQ, Xie H, Luo XH, Wu XP, Zhou HD, Lu Y, Liao EY (2006) Taurine transporter is expressed in osteoblasts. Amino Acids 31:157–163PubMedCrossRefGoogle Scholar
  10. 10.
    Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271–277PubMedCrossRefGoogle Scholar
  11. 11.
    Morgan DM (1998) Tetrazolium (MTT) assay for cellular viability and activity. Methods Mol Biol 79:179–183PubMedGoogle Scholar
  12. 12.
    Molinari BL, Tasat DR, Palmieri MA, Cabrini RL, O’Connor SE, Cabrini RL (2003) A cell-based quantitative evaluation of the MTT assay. Anal Quant Cytol Histol 25:254–262PubMedGoogle Scholar
  13. 13.
    Donahue HJ, Li Z, Zhou Z, Yellowley CE (2000) Differentiation of human fetal osteoblastic cells and gap junctional intercellular communication. Am J Physiol Cell Physiol 278:315–322Google Scholar
  14. 14.
    Stein GS, Lian JB (1993) Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of osteoblast phenotype. Endocr Rev 14:424–442PubMedCrossRefGoogle Scholar
  15. 15.
    Bortell R, Barone LM, Tassinari MS, Lian JB, Stein GS (1990) Gene expression during endochondral bone development: evidence for coordinate expression of transforming growth factor b and collagen type I. J Cell Biochem 44:81–91PubMedCrossRefGoogle Scholar
  16. 16.
    Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwisnse S, Lian JB, Stein GS (1990) Progressive development of the rat osteoblast phenotype in vitro: reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143:420–430PubMedCrossRefGoogle Scholar
  17. 17.
    Weinreb M, Shinar D, Rodan GA (1990) Different pattern of alkaline phosphatase, osteopontin and osteocalcin expression in developing rat bone visualized by in situ hybridization. J Bone Miner Res 5:831–842PubMedGoogle Scholar
  18. 18.
    Farley JR, Wergedal JE, Baylink DJ (1983) Fluoride directly stimulates proliferation and alkaline phosphatase activity of bone forming cells. Science 222:330–332PubMedCrossRefGoogle Scholar
  19. 19.
    Wergedal JE, Lau KH, Baylink DJ (1988) Fluoride and bovine bone extract influence cell proliferation and phosphatase activities in human bone cell cultures. Clin Orthop 233:274–282PubMedGoogle Scholar
  20. 20.
    Briancon D, Meunier PJ (1981) Treatment of osteoporosis with fluoride, calcium, and vitamin D. Orthop Clin N Am 12:629–648Google Scholar
  21. 21.
    Devogelaer JP, Nagant-de-Deuxchaisnes C, Clin R (1995) Fluoride therapy of type I osteoporosis. Clin Rheumatol 14:26–31PubMedCrossRefGoogle Scholar
  22. 22.
    Marie PJ, Vernejoul MC, Lomri A (1992) Stimulation of bone formation in osteoporosis patients treated with fluoride associated with increased DNA synthesis by osteoblastic cells in vitro. J Bone Miner Res 7:103–113PubMedGoogle Scholar
  23. 23.
    Kopp JB, Robey PG (1990) Sodium fluoride dose not increase human bone cell proliferation or protein synthesis in vitro. Calcified Tissue Int 47:221–229CrossRefGoogle Scholar
  24. 24.
    Torricelli P, Fini M, Giavaresi G (2003) Comparative interspecies investigation on osteoblast cultures: data on cell viability and synthetic activity. Biomed Pharmacother 57:57–62PubMedCrossRefGoogle Scholar
  25. 25.
    Burgener D, Bonjour JP, Caverzasio J (1995) Fluoride increases tyrosine kinase activity in osteoblast-like cells: regulatory role for the stimulation of cell proliferation and Pi transport across the plasma membrane. J Bone Miner Res 10:164–171PubMedCrossRefGoogle Scholar
  26. 26.
    Bely M, Ferencz G, Itai K (1997) Experimental osteofluorosis and arthrofluorosis in rats. Fluoride 30:113–114Google Scholar
  27. 27.
    Farley JR, Chesnut CH, Baylink DJ (1981) Improved method quantitative determination in serum of alkaline phosphatase of skeletal origin. Clin Chem 27:2002–2007PubMedGoogle Scholar

Copyright information

© Springer Japan 2008

Authors and Affiliations

  • Wei-Jie Qu
    • 1
  • Dai-Bin Zhong
    • 1
  • Pei-Fu Wu
    • 1
  • Jian-Fang Wang
    • 1
  • Bo Han
    • 1
    Email author
  1. 1.College of Veterinary MedicineChina Agricultural UniversityBeijingChina

Personalised recommendations